Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lam Research Corporation (LRCX) vs Nasdaq Inc (NDAQ) Price & Performance

Lam Research CorporationTrade
Nasdaq IncTrade

Price performance (Past 24H)

Key statistics

Lam Research Corporation vs Nasdaq Inc — how do they compare? Lam Research Corporation trades at $319 (market cap $401.19B), while Nasdaq Inc trades at $93.65 (market cap $51.63B). The key difference: Lam Research Corporation is far larger — about 7.8× Nasdaq Inc's market cap, and Nasdaq Inc pays the higher dividend (1.26%). Which is the better fit depends on your goals — on Pluang, investors hold Lam Research Corporation for 60 Days and Nasdaq Inc for 126 Days on average.

LRCXNDAQ
Market Cap
$401.19B$51.63B
Volume
8,960,8922,668,175
Sector
TechnologyFinancials
52-Week High
$433.33$100.98
52-Week Low
$131.37$76.85
Typical Hold Time
60 Days126 Days
Enterprise Value
$399.35B$58.09B
Dividend Yield
0.41%1.26%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lam Research Corporation

Lam Research (LRCX) trades at $318.84, down 3.24% on the day, with strong fundamentals including 29.06% net margin and consistent earnings beats. Technical indicators show a bearish short-term signal despite bullish moving averages, with key support at $314 and resistance at $329. Recent news highlights LRCX's positioning in AI-driven semiconductor equipment demand, with revenue growth accelerating to $18.44B in 2025.

Outlook remains positive with 78% analyst buy ratings and $375.68 consensus price target, representing 18% upside. Key risks include semiconductor cycle volatility and execution challenges in maintaining mid-40% operating margins. The stock offers growth exposure to AI infrastructure spending but faces competitive pressures in chip equipment markets.

Nasdaq Inc

Nasdaq Inc. (NDAQ) trades at $93.65, up 1.87% on the day, reflecting strong momentum. The stock exhibits a bullish technical signal with moving averages supporting further upside, while recent earnings beats and a 22.52% net income margin highlight robust profitability. Positive news includes the addition of Moderna to the Nasdaq-100 Index and HSBC adopting Nasdaq's Calypso platform, signaling business growth.

Outlook remains favorable with a consensus price target of $110.43, implying 18% upside. Key risks include cash flow volatility and high debt levels, but analyst sentiment is strongly bullish with 61% buy ratings. Revenue growth and AI-driven platform adoption present opportunities, though market volatility and competitive pressures warrant monitoring.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LRCX
95% Buy5% Sell
Avg holding period · 60 Days
NDAQ
51% Buy49% Sell
Avg holding period · 126 Days

Top news

Latest headlines on both assets

About Lam Research Corporation

Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.

Read more on LRCX →

About Nasdaq Inc

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.

Read more on NDAQ →